PPARA and lip and oral cavity carcinoma: The 10 significant pathways include C-X-C motif chemokine ligand 8 (CXCL8), peroxisome proliferator-activated receptor-alpha (PPARA), matrix metalloproteinase (MMP9), androgen receptor (AR), and mitogen-activated protein kinases (MAPK1), and they highlight the role of lauric acid through the PI3K/AKT pathway in oral cancer treatment [27].